Health · Full coverage
Startup Uses Personalized Scent Technology to Treat Sleep Problems
How 3 Israeli newsrooms covered this story — translated into English and compared side by side.
100% centerFirst reported by N12 · Jun 16, 2026
Center 2Unrated 1
What happened
Kimba, a startup founded by Ben Foxbrunner and Gabi Beck, raised $6.5 million to market an AI sleep device that uses personalized scent therapy. The company says clinical studies showed improved sleep and cognition, and it is already selling in the U.S. with an Israel launch planned.
- 01Kimba raised $6.5 million in seed funding for AI-based scent therapy.
- 02Founder Ben Foxbrunner built the product after PTSD and chronic insomnia.
- 03The system is sold in the U.S. for $299 and will soon launch in Israel.
- 04A 50-person study found 21% better cognition and 86% reported improved sleep.
- 05Two additional Israeli clinical studies are now testing the technology.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 3 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Israeli Startup Lets Small Businesses Make AI Ads in 30 Seconds4 days agoMerav Bahat Launches New Founders-First AI Fund With Assaf Rappaport2 days agoTwo Israeli Founders Aim for Nasdaq with AI Ordering Platform6 days agoLiad Agmon unveils a new hardware venture and says he is done selling software to middle-aged white menJun 17, 2026Lama AI Raises $12 Million to Speed Business Loan Approvals with AI Agents2 days agoDream Raises $260 Million, Triples Valuation to $3 BillionJun 18, 2026
